ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy

Background/Aim: Biliary tract cancer (BTC) has a poor prognosis due to its highly invasive and metastatic potential. Ataxia-telangiectasia mutated (ATM) is a key regulator of DNA damage response and an emerging therapeutic target; however, the association between the expression of ATM and the progno...

全面介紹

Na minha lista:
書目詳細資料
發表在:In Vivo
Main Authors: KIM, HYERA, KIM, SEUNG TAE, YOO, KWAI HAN, HONG, JUNG YONG, PARK, YOUNG SUK, LIM, HO YEONG, PARK, JOON OH
格式: Artigo
語言:Inglês
出版: International Institute of Anticancer Research 2021
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7880754/
https://ncbi.nlm.nih.gov/pubmed/33402502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12284
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍